UniSuper Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.39M | Buy |
8,368
+566
| +7% | +$297K | 0.03% | 271 |
|
|
2025
Q1 | $4.95M | Buy |
7,802
+496
| +7% | +$315K | 0.04% | 228 |
|
|
2024
Q4 | $5.2M | Buy |
7,306
+2,013
| +38% | +$1.43M | 0.04% | 219 |
|
|
2024
Q3 | $5.56M | Buy |
5,293
+144
| +3% | +$151K | 0.04% | 214 |
|
|
2024
Q2 | $5.41M | Buy |
5,149
+2,740
| +114% | +$2.88M | 0.04% | 204 |
|
|
2024
Q1 | $2.32M | Buy |
2,409
+1,530
| +174% | +$1.47M | 0.02% | 231 |
|
|
2023
Q4 | $772K | Sell |
879
-757
| -46% | -$665K | 0.01% | 285 |
|
|
2023
Q3 | $1.35M | Sell |
1,636
-198
| -11% | -$163K | 0.02% | 246 |
|
|
2023
Q2 | $1.32M | Buy |
+1,834
| New | +$1.32M | 0.02% | 251 |
|